Stonegate Investment Group LLC Has $879,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stonegate Investment Group LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 8.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,605 shares of the medical equipment provider’s stock after acquiring an additional 206 shares during the quarter. Stonegate Investment Group LLC’s holdings in Intuitive Surgical were worth $879,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. TIAA Trust National Association grew its holdings in Intuitive Surgical by 5.6% during the 4th quarter. TIAA Trust National Association now owns 2,156 shares of the medical equipment provider’s stock worth $727,000 after acquiring an additional 115 shares during the last quarter. Pinnacle Financial Partners Inc lifted its holdings in shares of Intuitive Surgical by 5.5% during the fourth quarter. Pinnacle Financial Partners Inc now owns 19,543 shares of the medical equipment provider’s stock worth $6,593,000 after purchasing an additional 1,012 shares during the period. Sigma Investment Counselors Inc. grew its stake in shares of Intuitive Surgical by 3.8% in the fourth quarter. Sigma Investment Counselors Inc. now owns 19,116 shares of the medical equipment provider’s stock worth $6,449,000 after purchasing an additional 706 shares during the last quarter. Spinnaker Investment Group LLC bought a new position in Intuitive Surgical during the 4th quarter worth $211,000. Finally, Norris Perne & French LLP MI grew its position in shares of Intuitive Surgical by 22.9% in the 4th quarter. Norris Perne & French LLP MI now owns 1,383 shares of the medical equipment provider’s stock valued at $467,000 after buying an additional 258 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on ISRG shares. StockNews.com lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, February 29th. Raymond James increased their price target on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a report on Thursday, January 25th. Truist Financial boosted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Piper Sandler raised their target price on Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research note on Wednesday, January 24th. Finally, Royal Bank of Canada boosted their price target on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $371.60.

Read Our Latest Report on ISRG

Intuitive Surgical Stock Down 3.2 %

Shares of Intuitive Surgical stock opened at $382.36 on Wednesday. The company has a market cap of $135.53 billion, a PE ratio of 76.02, a price-to-earnings-growth ratio of 6.13 and a beta of 1.36. Intuitive Surgical, Inc. has a 52 week low of $250.01 and a 52 week high of $403.76. The business has a 50 day moving average price of $386.82 and a 200-day moving average price of $335.66.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. The business had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.89 billion. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. Intuitive Surgical’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.91 EPS. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the sale, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the sale, the executive vice president now directly owns 189 shares in the company, valued at $69,958.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,373,093.80. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock worth $95,927,097 over the last quarter. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.